Jade Biosciences, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | +3,619.3% | -22.8% | -5.8% | -37.0% | +335.4% | |
| – | +3,628.3% | -24.6% | -5.5% | -35.5% | +319.6% | |
| – | +1,085.2% | -58.7% | +4.9% | +43.7% | +162.0% | |
| – | +3,560.1% | -22.8% | -5.2% | -35.8% | +327.6% | |
| – | +66.0% | +190.6% | +109.9% | -78.3% | +342.9% | |
| – | +43.7% | +205.2% | +126.6% | -78.3% | +332.1% | |
| – | – | +100.5% | +9.1% | -0.7% | – | |
| – | +95.5% | +113.2% | -7.0% | -90.7% | +860.3% | |
| – | – | – | – | – | – | |
| – | +5,762.6% | -26.5% | -13.6% | -30.2% | +335.0% | |
| – | – | – | – | – | – | |
| – | +0.0% | +0.3% | +7.6% | +8.5% | +3,740.1% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.